Thurs Jan 9th, the US Stock Markets will be closed in observance of a national day of mourning for former President Jimmy Carter. Read the press release here. Regular trading hours will resume tomorrow.
Cempra Inc (CEMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CEMP | ZTS | TAK | UTHR | NBIX |
| Company | Cempra Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 2.25 | 162.97 | 13.21 | 363.99 | 137.62 |
| High | 2.35 | 165.14 | 13.27 | 367.41 | 139.20 |
| Low | 2.20 | 161.38 | 13.14 | 360.00 | 137.00 |
| Last | 2.33 | 165.02 | 13.24 | 366.61 | 138.71 |
| Change | +0.03 | +1.53 | -0.11 | +4.28 | +1.16 |
| % Change | +1.30% | +0.94% | -0.82% | +1.18% | +0.84% |
| Volume | 511,600 | 2,353,100 | 4,788,200 | 252,700 | 899,000 |
| 20-Day Average Volume | 743,305 | 2,348,420 | 1,764,990 | 303,920 | 1,032,610 |
| Previous Close | 2.30 | 163.49 | 13.35 | 362.33 | 137.55 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.70 | 167.87 | 13.27 | 361.88 | 135.04 |
| 20-Day Raw Stochastic | 23.33% | 20.84% | 40.00% | 49.41% | 91.04% |
| 20-Day Relative Strength | 32.74% | 40.32% | 43.86% | 51.20% | 63.54% |
| Weighted Alpha | -52.60 | -16.45 | -11.25 | +60.26 | +6.53 |
| Today's Opinion | N/A | 88% Sell | 88% Sell | 56% Buy | 56% Buy |
| Previous Opinion | N/A | 88% Sell | 72% Sell | 56% Buy | 56% Buy |
| Last Month's Opinion | N/A | 40% Sell | 40% Sell | 80% Buy | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.65% since 10/27/17 | +1.28% since 12/31/24 | unch since 12/31/24 | +3.90% since 12/31/24 | +1.62% since 12/31/24 |
| Low | 2.10 on 10/30/17 | 160.59 on 01/03/25 | 13.14 on 01/08/25 | 350.93 on 01/02/25 | 136.13 on 01/06/25 |
| High | 2.45 on 11/01/17 | 167.58 on 01/06/25 | 13.45 on 01/07/25 | 367.41 on 01/08/25 | 139.72 on 01/06/25 |
| 1-Month | |||||
| %Chg | -29.39% since 10/03/17 | -6.48% since 12/06/24 | -3.57% since 12/06/24 | -0.83% since 12/06/24 | +8.25% since 12/06/24 |
| Low | 2.05 on 10/27/17 | 160.59 on 01/03/25 | 12.98 on 12/19/24 | 350.60 on 12/19/24 | 125.61 on 12/13/24 |
| High | 3.40 on 10/04/17 | 181.85 on 12/13/24 | 13.84 on 12/09/24 | 383.00 on 12/18/24 | 140.00 on 12/18/24 |
| 3-Month | |||||
| %Chg | -39.48% since 08/03/17 | -11.93% since 10/08/24 | -7.41% since 10/08/24 | +3.04% since 10/08/24 | +24.23% since 10/08/24 |
| Low | 2.05 on 10/27/17 | 160.59 on 01/03/25 | 12.98 on 12/19/24 | 342.02 on 10/23/24 | 111.14 on 10/10/24 |
| High | 4.40 on 08/09/17 | 196.55 on 10/17/24 | 14.36 on 10/18/24 | 417.82 on 11/08/24 | 140.00 on 12/18/24 |
| 6-Month | |||||
| %Chg | -39.48% since 05/03/17 | -5.93% since 07/08/24 | +0.46% since 07/08/24 | +15.69% since 07/08/24 | -2.48% since 07/08/24 |
| Low | 2.05 on 10/27/17 | 160.59 on 01/03/25 | 12.98 on 12/19/24 | 310.00 on 07/31/24 | 110.95 on 10/03/24 |
| High | 4.85 on 07/05/17 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 417.82 on 11/08/24 | 157.98 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 122,086 | 74,451,248 | 42,128,024 | 16,367,302 | 14,043,972 |
| Shares Outstanding, K | 52,510 | 451,165 | 3,181,875 | 44,645 | 101,247 |
| Annual Sales | 18,020,000 | 8,544,000,000 | 29,419,960,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -117,960,000 | 2,344,000,000 | 994,060,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 860,000 | 2,388,000,000 | 7,903,930,000 | 748,900,000 | 622,100,000 |
| Last Quarter Net Income | -12,270,000 | 682,000,000 | 618,620,000 | 309,100,000 | 129,800,000 |
| 60-Month Beta | 0.99 | 0.89 | 0.51 | 0.57 | 0.33 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.23 on 08/09/17 | 1.58 on 11/04/24 | 0.44 on 10/31/24 | 6.39 on 10/30/24 | 1.24 on 10/30/24 |
| Latest Earnings Date | 11/09/17 | 02/13/25 | 02/06/25 | 02/19/25 | 02/05/25 |
| Most Recent Dividend | N/A | 0.432 on 10/31/24 | 0.267 on 09/30/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 01/21/25 | 09/30/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.38 | 8.84 | 15.91 | 36.88 |